메뉴 건너뛰기
Emerging Infectious Diseases
Volumn 17, Issue 6, 2011, Pages 1099-1102
High vancomycin MIC and complicated methicillin-susceptible staphylococcus aureus bacteremia
Author keywords

[No Author keywords available]
Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CLINDAMYCIN; CLOXACILLIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METICILLIN; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;
EID: 79957628635     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1706.101037     Document Type: Article
Times cited : (72)
References (14)
  • 1
    • 50949085411 scopus 로고    scopus 로고
    • Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
    • doi:10.1128/AAC.00113-08
    • Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008;52:3315-3320. doi:10.1128/AAC.00113-08
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3315-3320
    • Lodise, T.P.1    Graves, J.2    Evans, A.3    Graffunder, E.4    Helmecke, M.5    Lomaestro, B.M.6
  • 2
    • 34447278781 scopus 로고    scopus 로고
    • Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
    • doi:10.1128/AAC.00939-06
    • Moise PA, Sakoulas G, Forrest A, Schentag JJ. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2007;51:2582-2586. doi:10.1128/AAC.00939-06
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 2582-2586
    • Moise, P.A.1    Sakoulas, G.2    Forrest, A.3    Schentag, J.J.4
  • 3
    • 2942558870 scopus 로고    scopus 로고
    • Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • doi:10.1128/JCM.42.6.2398-2402.2004
    • Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42:2398-2402. doi:10.1128/JCM.42.6.2398-2402.2004
    • (2004) J Clin Microbiol , vol.42 , pp. 2398-2402
    • Sakoulas, G.1    Moise-Broder, P.A.2    Schentag, J.3    Forrest, A.4    Moellering Jr., R.C.5    Eliopoulos, G.M.6
  • 4
    • 0038049117 scopus 로고    scopus 로고
    • Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia
    • Schwaber MJ, Wright SB, Carmeli Y, Venkataraman L, DeGirolami PC, Gramatikova A, et al. Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Emerg Infect Dis. 2003;9:657-664.
    • (2003) Emerg Infect Dis , vol.9 , pp. 657-664
    • Schwaber, M.J.1    Wright, S.B.2    Carmeli, Y.3    Venkataraman, L.4    Degirolami, P.C.5    Gramatikova, A.6
  • 5
    • 39449112495 scopus 로고    scopus 로고
    • Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • doi:10.1086/524667
    • Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:193-200. doi:10.1086/524667
    • (2008) Clin Infect Dis , vol.46 , pp. 193-200
    • Soriano, A.1    Marco, F.2    Martinez, J.A.3    Pisos, E.4    Almela, M.5    Dimova, V.P.6
  • 6
    • 70349909844 scopus 로고    scopus 로고
    • Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus
    • doi:10.1086/605636
    • Pillai SK, Wennersten C, Venkataraman L, Eliopoulos G, Moellering R, Karchmer A. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis. 2009;49:1169-1174. doi:10.1086/605636
    • (2009) Clin Infect Dis , vol.49 , pp. 1169-1174
    • Pillai, S.K.1    Wennersten, C.2    Venkataraman, L.3    Eliopoulos, G.4    Moellering, R.5    Karchmer, A.6
  • 7
    • 0034956360 scopus 로고    scopus 로고
    • Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides
    • doi:10.1128/JCM.39.7.2439-2444.2001
    • Walsh TR, Bolmstrom A, Qwarnstrom A, Ho P, Wootton M, Howe RA, et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol. 2001;39:2439-2444. doi:10.1128/JCM.39.7.2439-2444.2001
    • (2001) J Clin Microbiol , vol.39 , pp. 2439-2444
    • Walsh, T.R.1    Bolmstrom, A.2    Qwarnstrom, A.3    Ho, P.4    Wootton, M.5    Howe, R.A.6
  • 8
    • 34247282090 scopus 로고    scopus 로고
    • The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus
    • doi:10.1086/513203
    • Tenover FC, Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007;44:1208-1215. doi:10.1086/513203
    • (2007) Clin Infect Dis , vol.44 , pp. 1208-1215
    • Tenover, F.C.1    Moellering Jr., R.C.2
  • 9
    • 75649094556 scopus 로고    scopus 로고
    • Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?
    • doi:10.1086/649572
    • Lalueza A, Chaves F, San Juan R, Daskalaki M, Otero JR, Aguado JM. Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia? J Infect Dis. 2010;201:311-312. doi:10.1086/649572
    • (2010) J Infect Dis , vol.201 , pp. 311-312
    • Lalueza, A.1    Chaves, F.2    San, J.R.3    Daskalaki, M.4    Otero, J.R.5    Aguado, J.M.6
  • 10
    • 79957630822 scopus 로고    scopus 로고
    • Less Severity But Higher Risk of Late Complications In Methicillin-resistant Staphylococcus Aureus Bacteremia With a Vancomycin MIC >1.5 μg/mL
    • th Interscience Conference on Antimicrobials Agents and Chemotherapy. San Francisco: American Society for Microbiology
    • th Interscience Conference on Antimicrobials Agents and Chemotherapy. San Francisco: American Society for Microbiology; 2009.
    • (2009) Microbiology ASF
    • Lalueza, A.1    Chaves, F.2    San, J.R.3    Daskalaki, M.4    López-Medrano, M.5    Lizasoain, M.6
  • 11
    • 33846140488 scopus 로고    scopus 로고
    • Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
    • doi:10.1086/510386
    • Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis. 2007;44:190-196. doi:10.1086/510386
    • (2007) Clin Infect Dis , vol.44 , pp. 190-196
    • Stryjewski, M.E.1    Szczech, L.A.2    Benjamin Jr., D.K.3    Inrig, J.K.4    Kanafani, Z.A.5    Engemann, J.J.6
  • 12
    • 12244312162 scopus 로고    scopus 로고
    • Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus
    • doi:10.1128/JCM.41.1.5-14.2003
    • Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol. 2003;41:5-14. doi:10.1128/JCM.41.1.5-14.2003
    • (2003) J Clin Microbiol , vol.41 , pp. 5-14
    • Cui, L.1    Ma, X.2    Sato, K.3    Okuma, K.4    Tenover, F.C.5    Mamizuka, E.M.6
  • 13
    • 61849170591 scopus 로고    scopus 로고
    • Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection
    • doi:10.1086/596511
    • Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr, Eliopoulos GM. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis. 2009;199:532-536. doi:10.1086/596511
    • (2009) J Infect Dis , vol.199 , pp. 532-536
    • Peleg, A.Y.1    Monga, D.2    Pillai, S.3    Mylonakis, E.4    Moellering Jr., R.C.5    Eliopoulos, G.M.6
  • 14
    • 15944408935 scopus 로고    scopus 로고
    • Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain
    • doi:10.1086/502519
    • Chaves F, Garcia-Martinez J, de Miguel S, Sanz F, Otero JR. Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain. Infect Control Hosp Epidemiol. 2005;26:150-156. doi:10.1086/502519
    • (2005) Infect Control Hosp Epidemiol , vol.26 , pp. 150-156
    • Chaves, F.1    Garcia-Martinez, J.2    de Miguel, S.3    Sanz, F.4    Otero, J.R.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.